MissionIR Articles
Original content written and distributed as part of our ongoing relationships.
-
MissionIRNewsBreaks – VistaGen Therapeutics (NASDAQ: VTGN) Featured in Research Report
VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (“CNS”) disorders, was featured in a recent research report by Aegis Capital Corp. The report…
-
MissionIRNewsBreaks – The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) Announces Board Appointment of Seasoned Retail Veteran
The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused drinking waters and CBD-infused products, today announced the appointment of retail industry veteran Frank Lazaran to its board of…
-
MissionIRNewsBreaks – Why VistaGen Therapeutics (NASDAQ: VTGN) Is ‘One to Watch’
VistaGen Therapeutics (NASDAQ: VTGN) is a biopharmaceutical company committed to developing and commercializing a new generation of medications that go beyond the standard of care for anxiety, depression and other central nervous system (“CNS”) disorders.…
-
SRAX Inc. (NASDAQ: SRAX) Announces Acquisition of Micro-Cap Specialist Data Company, LD Micro
SRAX has announced acquisition of LD Micro, a leading data company serving small and micro-cap listed company space SRAX will pay gross consideration of 1.6 million new SRAX shares along with four $1 million installments…
-
MissionIRNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Further Strengthens Market Presence in Education Sector
Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a leading producer, developer and operator of augmented reality (“AR”) interactive entertainment games, toys and educational materials in China, today announced a strategic collaboration. According to the update,…
-
MissionIRNewsBreaks – Genprex Inc. (NASDAQ: GNPX) CEO Scheduled to Present at LD Micro Event
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, is slated to present at an upcoming LD Micro virtual event. GNPX’s Zoom presentation is scheduled for…
-
MissionIRNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Closing of Public Offering
Processa Pharmaceuticals (NASDAQ: PCSA) has closed its previously announced underwritten public offering of 4,800,000 shares of common stock, which were offered to the public for $4 per share. The clinical-stage biopharmaceutical company, which focuses on…
-
MissionIRNewsBreaks – 180 Life Sciences Corp. Continues to Broaden Global IP Portfolio, Expand Internal Pipeline
KBL Merger Corp. (NASDAQ: KBLM) (KBL Merger Corp. Rights NASDAQ: KBLMR) (KBL Merger Corp. Warrant NASDAQ: KBLMW), a Special Purpose Acquisition Corporation (SPAC) that previously entered a definitive agreement to acquire 180 Life Sciences, a…
-
Net Element Inc. (NASDAQ: NETE), Mullen Technologies Announce Facility Build-Out, Pre-Sales of Fully Electric EV
Mullen Technologies begins built-out of pilot facility, accepting orders for MX-05 SUV. Facility slated for April 2021 completion; first MX-05 SUVs rolling off production line by Q2 2022. In August, Net Element, Mullen Technologies announced…
-
MissionIRNewsBreaks – The Alkaline Water Company Inc.’s (CSE: WTER) (NASDAQ: WTER) A88 Infused(TM) Grabbing Shelf Space in Trend Expected to Accelerate
The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused drinking waters and CBD-infused products, today announced that its A88 Infused(TM) brand is gaining ground in the fast-growing flavored…
-
MissionIRNewsBreaks – Predictive Oncology (NASDAQ: POAI) Shareholder Letter Provides Company Update, Status of Subsidiaries
Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has released a shareholder letter providing a review of where POAI “stands as of today.” The…
-
Processa Pharmaceuticals Inc. (NASDAQ: PCSA) is “One to Watch”
Processa Pharmaceuticals aims to develop products where existing clinical evidence of efficacy already exists in the targeted unmet medical need condition with the drug itself or a drug with very similar pharmacology The Processa process…
-
MissionIRNewsBreaks – Pressure BioSciences (PBIO) Locks In Final System Design, Begins Production of Alpha Unit
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, and other industries, has reached what it calls as…
-
MissionIRNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Announces ‘Clean Slate’ from Debt Coupled with Strong Working Capital
Energy Fuels (NYSE American: UUUU) (TSX: EFR), the leading uranium producer in the United States, today announced that the company became debt-free following the retirement of its remaining C$10,430,000 of floating-rate convertible unsecured subordinated debentures…
-
MissionIRNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Secures DOE Grant for Production of Rare Earth Elements
Energy Fuels (NYSE American: UUUU) (TSX: EFR), the leading producer of uranium in the United States, along with a team from Penn State University recently announced the award of a contract from the U.S. Department…
-
MissionIRNewsBreaks – 180 Life Sciences Corp. Announces New Board Appointments
KBL Merger Corp. (NASDAQ: KBLM) (KBL Merger Corp. Rights NASDAQ: KBLMR) (KBL Merger Corp. Warrant NASDAQ: KBLMW), a Special Purpose Acquisition Corporation (SPAC) that previously entered a definitive agreement to acquire 180 Life Sciences, a…
-
CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Partnership with Imaging Specialists IAG Gives Tech Boost to Upcoming Brain Cancer Drug Trials
Clinical-stage biotech developer CNS Pharmaceuticals is working to demonstrate the potential effectiveness of its novel drug, Berubicin, in treating aggressive and rare brain cancer glioblastoma multiforme (“GBM”) CNS expects to launch Phase II trials of…
-
Revenue Growth Amid Pandemic Helps Trxade Group, Inc. (NASDAQ: MEDS) Build its Transparency in Pharmaceuticals Strategy
Pharmaceutical services innovator Trxade Group Inc. has gained investor attention as it has emerged as a responsive healthcare market force during the ongoing COVID-19 pandemic As the pandemic began to unfold earlier this year, Trxade…
-
MissionIRNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Appoints Digital Media Exec as BIGtoken CEO
SRAX (NASDAQ: SRAX), a financial technology solutions provider, today announced that one of its board members, Malcolm CasSelle, will be appointed chief executive officer of BIGtoken, a wholly owned subsidiary of SRAX. In addition to…
-
MissionIRNewsBreaks – Youngevity International Inc. (NASDAQ: YGYI) Issues Update on Non-Compliance with Nasdaq Listing Requirements
Youngevity International (NASDAQ: YGYI), a leading multichannel lifestyle company operating in three distinct business segments, on Friday announced its receipt of a September 29, 2020, Staff Determination Letter (the “September Notification”) from the Listing Qualifications…
-
MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) CEO Discusses Strategic Business Models, Nascent Stage of B2C Platform
Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and health-care platform, showcased its powerful capabilities during a recent virtual investor summit. Trxade Group’s CEO Suren Ajjarapu presented for the company to discuss the platform, which…
-
MissionIRNewsBreaks – Cybin Corp. CEO Eyes Opportunity in Psychedelics Space, Organic IP Expansion
Cybin Corp., a Canada-based, life-science company developing mushroom-derived psychedelic pharmaceuticals and nonpsychedelic nutraceutical products, recently announced the appointment of Doug Drysdale as the company’s chief executive officer. Well recognized in the pharmaceutical space, Drysdale brings…
-
MissionIRNewsBreaks – Predictive Oncology Inc.’s (NASDAQ: POAI) Helomics CIO Discusses Convergence of AI, Data and Biology on DojoLIVE!
Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, was featured in a recent article discussing the appearance of one of its executives, Helomics CIO…
-
MissionIRNewsBreaks – 180 Life Sciences Corp. Setting the Stage for Success in Bringing Novel Products to Market
180 Life Sciences, a clinical-stage biotechnology company, is focused on research to solve one of the world’s most significant drivers of disease – inflammation. The company currently has three programs for the development of novel…
-
MissionIRNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Applauds President Trump’s Bold Action to Address Threat of Foreign Reliance on Critical Minerals
Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading producer of uranium and vanadium in the United States, on Thursday announced that President Trump issued an Executive Order on Addressing the Threat to the Domestic…
-
VistaGen Therapeutics Inc. (NASDAQ: VTGN) is “One to Watch”
VistaGen’s product portfolio consists of three novel drug candidates that, together, target multiple anxiety disorders, depression disorders and neurological disorders Two of the company’s drug candidates have received an FDA fast track designation, including for…
-
MissionIRNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Pricing of $19.2M Public Offering, Nasdaq Uplisting
Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company focused on the development of drug products for patients with high unmet medical need conditions or no alternative treatment options, today announced the pricing of an underwritten…
-
Trxade Group, Inc. (NASDAQ: MEDS) Ending Q3 Strong with Increased Investor Exposure
The company’s current independent pharmacy member base represents over 50% of the United States pharmaceutical market within that vertical Actively used in all 50 states with over 11,700 pharmacies in its network, serving around 15…
-
MissionIRNewsBreaks – Mullen Technologies Opens Pre-Sales for MX-05 Pure Electric SUV
Mullen Technologies Inc., an emerging electric vehicle (“EV”) manufacturer, which previously announced a definitive agreement to merge with Net Element (NASDAQ: NETE) in a stock-for-stock reverse merger, today announced that it is accepting preorders for its…
-
MissionIRNewsBreaks – The Alkaline Water Company Inc.’s (CSE: WTER) (NASDAQ: WTER) A88 Infused(TM) to be Featured by DOT Foods as All-Natural Flavored Product
The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused drinking waters and CBD-infused products, today announced that its A88 Infused(TM) flavors will be a featured product offered by…
-
MissionIRNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Announces BIGtoken to Become Separate Public Company
SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies, will be moving its BIGtoken platform to a separate, publicly traded company. BIGtoken empowers consumers to earn money and…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Achieves Critical Milestone for Production of Lead Drug Candidate
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that its GMP manufacturer partner NCK A/S,…
-
MissionIRNewsBreaks – VistaGen Therapeutics (NASDAQ: VTGN) CEO Discusses ‘Sea of Change’ to Future of Anxiety Treatment
VistaGen Therapeutics’ (NASDAQ: VTGN) CEO Shawn Singh authored a recent article for Life Science Leader titled, “The Future of Anxiety Treatment Will Be Drastically Different.” In the piece, Singh, an experienced professional who has dedicated…
-
MissionIRNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Enters Updated LOI to Acquire 51% of Mobile Game Developer Csfctech
Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a leading producer, developer and operator of augmented reality (“AR”) interactive entertainment games, toys and educational materials in China, today announced its entry into an updated letter of…
-
MissionIRNewsBreaks – Creatd Inc. (NASDAQ: CRTD) Appoints New COO to Lead Growth Strategy, Manage Partnership Initiatives
Creatd (NASDAQ: CRTD, CRTDW), the parent company and creator of the Vocal platform, today announced the appointment of Laurie Weisberg as its new chief operating officer. Weisberg currently sits on Creatd’s board of directors and…
-
MissionIRNewsBreaks – VistaGen Therapeutics (NASDAQ: VTGN) CEO Addresses ‘Multi-Pronged Approach’ to Growing Problem of Workplace Stress and Anxiety
VistaGen Therapeutics’ (NASDAQ: VTGN) CEO Shawn Singh authored a recent article for Business.com regarding the COVID-19 pandemic and resulting stress and anxiety impacts to the workplace. In the piece, Singh indicates that stress and anxiety,…
-
MissionIRNewsBreaks – VistaGen Therapeutics (NASDAQ: VTGN) CEO Discusses PH94B Drug Candidate in Applied Clinical Trials Publication
VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (“CNS”) disorders, was recently featured in an Applied Clinical Trials article titled, “Pushing Late-Stage Treatments Forward…
-
Predictive Oncology Inc. (NASDAQ: POAI) Set to Capitalize on Increased AI Usage within Oncological Treatments
Predictive Oncology develops AI-solutions designed to assist clinicians in formulating personalized treatment plans for oncological patients Artificial Intelligence is being increasingly used to help understand and accurately predict how drug therapies can interact with specific…
-
CNS Pharmaceuticals, Inc. (CNSP) Expands Scientific Advisory Board with Leading Neuro-Oncology Expert, Dr. Patrick Wen, M.D.
Pivotal Phase 2 Berubicin trial expected to commence in Q1 2021 following planned IND submission in Q4 2020 CNS Pharmaceuticals also plans to begin pre-clinical work on Berubicin in connection with treatment for lymphomas, pancreatic,…
-
SRAX Inc. (NASDAQ: SRAX) Acquires LD Micro, Accelerates Adoption of SaaS Data Management Platform
SRAX recently closed acquisition of LD Micro, leading micro-cap information portal LD Micro to become wholly-owned subsidiary of SRAX for 1.6 million in common stock plus $4 million cash Acquisition to accelerate adoption of Sequire,…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Eyes Expanded 4E Reserves, Cost Efficiencies at Waterberg
- MissionIRNewsBreaks – Why GlobalTech Corp. (GLTK) Is ‘One to Watch’
- Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ): Advancing Critical Minerals in Alaska’s Ambler Mining District
- Safe Pro Group Inc. (NASDAQ: SPAI) Partners with Drone Industry Leaders to Advance AI-Powered Threat Detection
- PowerBank Corporation’s (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) 5.7 MW North Main St Project Clears Interconnection Study, Moves Toward Permitting